Englander Institute for Precision Medicine

PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes.

TitlePDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes.
Publication TypeJournal Article
Year of Publication2022
AuthorsClement CC, Osan J, Buqué A, Nanaware PP, Chang Y-C, Perino G, Shetty M, Yamazaki T, Tsai WLi, Urbanska AM, J Calvo-Calle M, Ramsamooj S, Ramsamooj S, Vergani D, Mieli-Vergani G, Beretta-Piccoli BTerziroli, Gadina M, Montagna C, Goncalves MDaSilva, Sallusto F, Galluzzi L, Soni RK, Stern LJ, Santambrogio L
JournalSci Immunol
Volume7
Issue74
Paginationeabl3795
Date Published2022 Aug 12
ISSN2470-9468
KeywordsAnimals, Autoimmunity, Diabetes Mellitus, Type 2, Epitopes, Histocompatibility Antigens Class II, Liver, Mice, Peptides, Protein Disulfide-Isomerases
Abstract

A diet rich in saturated fat and carbohydrates causes low-grade chronic inflammation in several organs, including the liver, ultimately driving nonalcoholic steatohepatitis. In this setting, environment-driven lipotoxicity and glucotoxicity induce liver damage, which promotes dendritic cell activation and generates a major histocompatibility complex class II (MHC-II) immunopeptidome enriched with peptides derived from proteins involved in cellular metabolism, oxidative phosphorylation, and the stress responses. Here, we demonstrated that lipotoxicity and glucotoxicity, as driven by a high-fat and high-fructose (HFHF) diet, promoted MHC-II presentation of nested T and B cell epitopes from protein disulfide isomerase family A member 3 (PDIA3), which is involved in immunogenic cell death. Increased MHC-II presentation of PDIA3 peptides was associated with antigen-specific proliferation of hepatic CD4 immune infiltrates and isotype switch of anti-PDIA3 antibodies from IgM to IgG3, indicative of cellular and humoral PDIA3 autoreactivity. Passive transfer of PDIA3-specific T cells or PDIA3-specific antibodies also exacerbated hepatocyte death, as determined by increased hepatic transaminases detected in the sera of mice subjected to an HFHF but not control diet. Increased humoral responses to PDIA3 were also observed in patients with chronic inflammatory liver conditions, including autoimmune hepatitis, primary biliary cholangitis, and type 2 diabetes. Together, our data indicated that metabolic insults caused by an HFHF diet elicited liver damage and promoted pathogenic immune autoreactivity driven by T and B cell PDIA3 epitopes.

DOI10.1126/sciimmunol.abl3795
Alternate JournalSci Immunol
PubMed ID35984892
PubMed Central IDPMC9762167
Grant ListR01 AI137198 / AI / NIAID NIH HHS / United States
R01 AI146180 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021